SINOVAC BIOTECH LTD

Biopharmaceutical firm developing vaccines against infectious diseases like COVID-19 and Hepatitis.

SVA | US

Overview

Corporate Details

ISIN(s):: AGP8696W1045
LEI:
Country:: United States of America
Address:: NO. 39 SHANGDI XI ROAD, 100085 BEIJING
Website:: http://www.sinovac.com/
Sector:: Manufacturing
Industry:: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Sinovac Biotech Ltd. is a biopharmaceutical company focused on the research, development, manufacturing, and commercialization of vaccines that protect against human infectious diseases. The company's commercialized product portfolio includes vaccines for COVID-19 (CoronaVac®), hepatitis A (Healive®), combined hepatitis A and B (Bilive®), influenza, enterovirus 71 (Inlive®), polio, pneumonia, and chickenpox. Sinovac has achieved significant milestones, including developing a globally pioneered EV71 vaccine and China's only independently developed Hepatitis A and B combination vaccine. Several of its products have received World Health Organization (WHO) prequalification, and its CoronaVac® vaccine is included in the WHO's Emergency Use Listing.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all SINOVAC BIOTECH LTD filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for SINOVAC BIOTECH LTD

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for SINOVAC BIOTECH LTD via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
Connect Biopharma Holdings Ltd Develops immune modulators for T cell-driven inflammatory diseases like asthma and COPD.	United States of America	CNTB
Context Therapeutics Inc. Clinical-stage biopharma developing T cell engaging bispecific antibodies for solid tumors.	United States of America	CNTX
Contineum Therapeutics, Inc. Develops oral small molecule therapies for neurological, inflammatory, and fibrotic diseases.	United States of America	CTNM
CORCEPT THERAPEUTICS INC Develops and commercializes cortisol-modulating drugs for severe disorders like Cushing's syndrome.	United States of America	CORT
CORESTEMCHEMON Inc. Develops stem cell therapies & provides preclinical CRO services to pharma & biotech.	South Korea	166480
Corline Biomedical AB Develops heparin-based coatings for medical device biocompatibility and regenerative medicine.	Sweden	CLBIO
CorMedix Inc. Develops a catheter lock solution to prevent bloodstream infections in hemodialysis patients.	United States of America	CRMD
Cosma Spolka Akcyjna Produces natural hemp supplements and pharmaceutical raw materials for retail & wholesale markets.	Poland	COS
COSMO Pharmaceuticals N.V. Specialty pharma for gastroenterology/dermatology, offering colon treatments & manufacturing services.	Netherlands	COPN
Cosmos Health Inc. A global healthcare firm developing & distributing nutraceuticals, generics, and OTC medications.	United States of America	COSM